Change to the shareholder structure of the Galenica Group

Monday, 9 January 2017, ↓ directly to download

Sprint Investments 2 no longer holds stake in Galenica Group
Broad placement of shares among various investors with long-term investment focus

The long-standing principal shareholder of Galenica Group, Sprint Investments 2 GmbH, has divested itself of its financial stake in full. As Galenica wished, the shares were placed broadly among various investors with a long-term investment focus.

Read more

Galenica is a diversified Group active throughout the healthcare market which, among other activities, develops, manufactures and markets pharmaceutical products, runs pharmacies, provides logistical and database services and sets up networks. With its two Business units Vifor Pharma and Galenica Santé, the Galenica Group enjoys a leading position in all its core business activities. A large part of the Group's income is generated by international operations. Galenica is listed on the Swiss Stock Exchange (SIX Swiss Exchange, GALN, security number 1,553,646).

Galenica AG published this content on 09 January 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 09 January 2017 06:03:48 UTC.

Original documenthttp://www.galenica.com/en/medien/medienmitteilungen/2017/20170109_7172263064_meldung.php

Public permalinkhttp://www.publicnow.com/view/97A4F82CDC33C87E3AD16C6A13BEEE21B2070738